Vesalius Biocapital Partners
Strassen, Canton of Luxembourgvesaliusbiocapital.com
Overview
Vesalius Biocapital Partners is a European life sciences venture capital investor. They invest in companies active in human health through venture capital funds raised since 2007, focusing on therapeutics, medical devices & diagnostics and eHealth / mHealth. They finance both early stage companies and corporate spin-offs with more mature assets.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nutrium | Sep 2025 | Series A | Lead |
| ENYO Pharma | Jun 2025 | Series C Extension | Lead |
| HepaRegeniX GmbH | Apr 2025 | Series C | Lead |
| Inflammatix | Sep 2024 | Series E | Co-investor |
| Caresyntax | Aug 2024 | Debt | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
